Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Statistics

Total Valuation

SHE:301207 has a market cap or net worth of CNY 11.29 billion. The enterprise value is 8.21 billion.

Market Cap	11.29B
Enterprise Value	8.21B

Important Dates

The next estimated earnings date is Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	Oct 27, 2025

Share Statistics

SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -1.11% in one year.

Current Share Class	595.00M
Shares Outstanding	595.00M
Shares Change (YoY)	-1.11%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	2.01%
Float	79.97M

Valuation Ratios

The trailing PE ratio is 160.19 and the forward PE ratio is 10.48.

PE Ratio	160.19
Forward PE	10.48
PS Ratio	11.56
PB Ratio	1.99
P/TBV Ratio	2.00
P/FCF Ratio	40.02
P/OCF Ratio	37.70
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 134.86, with an EV/FCF ratio of 29.11.

EV / Earnings	116.53
EV / Sales	8.41
EV / EBITDA	134.86
EV / EBIT	n/a
EV / FCF	29.11

Financial Position

The company has a current ratio of 3.26

Current Ratio	3.26
Quick Ratio	3.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.71

Financial Efficiency

Return on equity (ROE) is 1.20% and return on invested capital (ROIC) is -2.92%.

Return on Equity (ROE)	1.20%
Return on Assets (ROA)	-0.67%
Return on Invested Capital (ROIC)	-2.92%
Return on Capital Employed (ROCE)	-1.39%
Revenue Per Employee	1.31M
Profits Per Employee	94,203
Employee Count	748
Asset Turnover	0.13
Inventory Turnover	1.13

Taxes

Income Tax	-24.19M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.20% in the last 52 weeks. The beta is 0.77, so SHE:301207's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+11.20%
50-Day Moving Average	20.83
200-Day Moving Average	18.55
Relative Strength Index (RSI)	41.30
Average Volume (20 Days)	7,056,519

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301207 had revenue of CNY 976.44 million and earned 70.46 million in profits. Earnings per share was 0.12.

Revenue	976.44M
Gross Profit	685.60M
Operating Income	-79.51M
Pretax Income	46.27M
Net Income	70.46M
EBITDA	60.89M
EBIT	-79.51M
Earnings Per Share (EPS)	0.12

Balance Sheet

The company has 3.08 billion in cash and n/a in debt, with a net cash position of 3.08 billion or 5.17 per share.

Cash & Cash Equivalents	3.08B
Total Debt	n/a
Net Cash	3.08B
Net Cash Per Share	5.17
Equity (Book Value)	5.67B
Book Value Per Share	9.54
Working Capital	3.32B

Cash Flow

In the last 12 months, operating cash flow was 299.36 million and capital expenditures -17.32 million, giving a free cash flow of 282.04 million.

Operating Cash Flow	299.36M
Capital Expenditures	-17.32M
Free Cash Flow	282.04M
FCF Per Share	0.47

Margins

Gross margin is 70.21%, with operating and profit margins of -8.14% and 7.22%.

Gross Margin	70.21%
Operating Margin	-8.14%
Pretax Margin	4.74%
Profit Margin	7.22%
EBITDA Margin	6.24%
EBIT Margin	-8.14%
FCF Margin	28.88%

Dividends & Yields

This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 3.18%.

Dividend Per Share	0.60
Dividend Yield	3.18%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	4
Payout Ratio	196.37%
Buyback Yield	1.11%
Shareholder Yield	4.31%
Earnings Yield	0.62%
FCF Yield	2.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 7, 2023
Split Type	Forward
Split Ratio	1.5

Scores

SHE:301207 has an Altman Z-Score of 5.34 and a Piotroski F-Score of 4.

Altman Z-Score	5.34
Piotroski F-Score	4